周三盘中，医疗设备制造商波士顿科学（Boston Scientific）股价大涨5.23%，引发市场广泛关注。这一股价上涨主要受到公司发布的强劲第二季度财报以及上调全年盈利指引的推动。
根据公司公布的财报，波士顿科学第二季度销售额同比增长23%至50.6亿美元，超过分析师平均预期的48.9亿美元。其中，心血管设备销售表现尤为亮眼，增长29%至26.5亿美元。公司净利润达到7.97亿美元，同比大幅增长约146%。调整后每股收益为0.75美元，同样超出分析师预期的0.73美元。
受此优异业绩的推动，波士顿科学上调了2025年全年盈利指引。公司预计调整后每股收益将在2.95至2.99美元之间，高于此前2.87至2.94美元的预期。分析师指出，公司核心产品如Farapulse和Watchman的强劲需求是推动业绩增长的主要因素。这一系列积极信号显示了波士顿科学在医疗设备市场的强劲竞争力和良好的发展前景，从而推动了投资者的信心和股价的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.